Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

500 trials

NCT06982820
Recruiting
Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia
Not applicable · Israel, United States · 3 sites
Registry update: 1 May 2026
NCT07065240
Recruiting
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Phase 2 · Bulgaria, Czechia, Germany, Hungary, Poland, Romania, Slovakia, United States · 59 sites
Registry update: 6 Oct 2026
NCT07039370
Recruiting
Molecular Signatures of TMS Response in Treatment-Resistant Depression
Not applicable · 1 site
Registry update: 11 Sept 2026
NCT07015944
Recruiting
Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in Pakistan
Not applicable · Pakistan · 1 site
Registry update: 18 Mar 2026
NCT07113548
Recruiting
PERSONAE - a Personalized Online Treatment of Depression
Not applicable · Denmark · 1 site
Registry update: 15 Aug 2025
NCT07500714
Recruiting
Integrating Digital Phenotypes and AI-Driven Cognitive-Behavioral Therapy: Advancing Precision Medicine in Depression Through Digital Medicine
Not applicable · Taiwan · 1 site
Registry update: 30 Mar 2026
NCT07028216
Recruiting
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
Not applicable · United States · 1 site
Registry update: 5 May 2026
NCT07033780
Recruiting
Theta-Burst Stimulation to Treat Depression
Phase 1 · Canada · 1 site
Registry update: 24 Jun 2025
NCT07706478
Recruiting
Working Mechanisms and Effectiveness of IV Ketamine-assisted Psychotherapy on Depression in TRD Clients
Not applicable · Netherlands · 1 site
Registry update: 15 Jul 2026
NCT07474363
Recruiting
Gender Differences in Depression Severity, Gender-Sensitive Symptoms, Resilience, and Stigma in Major Depressive Disorder
Not applicable · 1 site
Registry update: 25 Mar 2026
NCT06963021
Recruiting
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Phase 3 · Belgium, Canada, Finland, United Kingdom, Hungary, Latvia, United States · 34 sites
Registry update: 10 Aug 2026
NCT06072898
Recruiting
A Randomized Neuroimaging Trial of Psilocybin in Depression
Phase 2 · Canada · 1 site
Registry update: 30 Mar 2026
2024-515395-12-00
Recruiting
Randomized, placebo-controlled clinical trial to investigate the safety and efficacy of two dexamfetamine sulfate formulations in adults with ADHD and moderate to severe depression (DEXAD)
Phase 2 · Germany · 5 sites
Registry update: 28 Aug 2026
NCT07041073
Recruiting
EEG-based Neurofeedback to Improve Emotion Regulation in Major Depressive Disorder: A Randomized Clinical Trial
Not applicable · Spain · 1 site
Registry update: 27 Jun 2025
NCT06967857
Recruiting
Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression
Phase 2 · Germany · 5 sites
Registry update: 25 Sept 2026
NCT05295888
Recruiting
Temporal Interference and Depression
Not applicable · Canada · 1 site
Registry update: 24 Apr 2025
NCT07604753
Recruiting
Validation of the CIDI 5.0 Against the SCID-5 for Lifetime Mental Disorders
Not applicable · Hong Kong · 1 site
Registry update: 22 May 2026
NCT06748209
Recruiting
Establishing Mobile Transcranial Magnetic Stimulation
Phase 4 · United States · 1 site
Registry update: 6 May 2026
NCT07129941
Recruiting
Unified Protocol Group Treatment in a University Outpatient Clinic
Not applicable · Norway · 1 site
Registry update: 19 Aug 2025
NCT06620276
Recruiting
ACT_for Alcohol Use Disorder and Depression
Not applicable · Canada · 1 site
Registry update: 5 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.